Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-21.63 Insider Own0.10% Shs Outstand327.43M Perf Week2.79%
Market Cap45.44B Forward P/E8.07 EPS next Y17.20 Insider Trans0.54% Shs Float326.90M Perf Month-1.09%
Income-7232.60M PEG- EPS next Q4.30 Inst Own88.60% Short Float1.00% Perf Quarter0.59%
Sales15.71B P/S2.89 EPS this Y24.90% Inst Trans-1.88% Short Ratio1.43 Perf Half Y-12.01%
Book/sh185.37 P/B0.75 EPS next Y3.30% ROA-7.00% Target Price178.84 Perf Year-13.39%
Cash/sh5.45 P/C25.48 EPS next 5Y3.33% ROE-10.80% 52W Range125.84 - 197.00 Perf YTD3.83%
Dividend2.96 P/FCF10.90 EPS past 5Y-36.00% ROI-4.80% 52W High-29.74% Beta1.32
Dividend %2.13% Quick Ratio0.60 Sales past 5Y43.40% Gross Margin86.20% 52W Low10.00% ATR4.09
Employees16900 Current Ratio0.70 Sales Q/Q-2.00% Oper. Margin-49.00% RSI (14)42.14 Volatility2.96% 2.85%
OptionableYes Debt/Eq0.38 EPS Q/Q-629.90% Profit Margin-45.90% Rel Volume0.58 Prev Close138.78
ShortableYes LT Debt/Eq0.32 EarningsMay 07 BMO Payout- Avg Volume2.27M Price138.42
Recom2.20 SMA20-2.30% SMA50-4.66% SMA200-13.20% Volume203,693 Change-0.26%
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-19 01:18PM  Time to buy ArcelorMittal? Any interest in Alibaba? What about Fitbit? The viewers #AskHalftime CNBC Videos
May-19-19 10:26PM  Edited Transcript of AGN earnings conference call or presentation 7-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-17-19 07:30AM  Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire
May-16-19 09:20AM  Consider This Before Buying Allergan plc (NYSE:AGN) For The 2.2% Dividend Simply Wall St.
07:30AM  Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire
May-15-19 05:08PM  Wallace Weitz Exits Allergan, Trims Liberty Broadband Position GuruFocus.com
07:30AM  Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health PR Newswire
06:00AM  PatientFi® Announces Study Partnership with Allergan Business Wire
May-13-19 03:00PM  Leidos feels effects of a nationally known corporate gadfly American City Business Journals
02:38PM  Drug price fixing allegation may be increasingly problematic for makers: Analyst CNBC Videos
09:27AM  5 Growthy Biotech Stocks to Buy Despite the Scrutiny InvestorPlace
May-10-19 07:34AM  Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug Zacks
May-09-19 07:30AM  Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference PR Newswire
May-08-19 03:17PM  Botox Competitor Aims to Take Market Share as Allergan Stumbles Bloomberg
May-07-19 04:32PM  Allergan Fended Off Botox Rivalries In The First Quarter But Can It Last? Investor's Business Daily
04:15PM  Allergan stock slips despite revenue beat, a sign of investors worries over companys future MarketWatch
03:21PM  Epipen Parent's Faceplant Is a Cautionary Tale for Botox Maker Bloomberg
03:00PM  What You Need to Know About Allergan's Solid Q1 Performance Motley Fool
01:23PM  Allergan PLC (AGN) Q1 2019 Earnings Call Transcript Motley Fool
01:20PM  Regeneron Stock Could Fall 13% to 52-Week Lows TheStreet.com
12:20PM  Allergan CEO says company is urgently looking at all options to boost share price Reuters
12:06PM  Dow falls 400 points as stocks retreat for second day on U.S.-China tariff worries MarketWatch
09:51AM  Allergan Tops Q1 Earnings Estimate, Boosts Full-Year Profit Outlook TheStreet.com
09:27AM  Allergan (AGN) Beats on Q1 Earnings & Sales, Raises '19 View Zacks
08:59AM  Allergan Stock Slips Despite Beat and Raised Guidance TheStreet.com
08:25AM  Allergan (AGN) Q1 Earnings and Revenues Top Estimates Zacks
07:59AM  Stocks making the biggest moves premarket: Ferrari, Boeing, PepsiCo, Mosaic, Hertz, AIG & more CNBC
07:49AM  Allergan lifts outlook after Botox plumps quarterly earnings Financial Times
07:34AM  Allergan stock down 0.5% despite earnings and revenue beat MarketWatch
07:30AM  Allergan: 1Q Earnings Snapshot Associated Press
07:08AM  Allergan reports bigger first-quarter loss on $2.5 bln charge Reuters
07:00AM  Allergan Reports First Quarter 2019 Financial Results PR Newswire
04:10AM  Stocks - AIG Jumps in Premarket, Anheuser Busch, Boeing Fall, Alphabet Dips Investing.com
02:56AM  Stocks - U.S. Futures Head Lower Again on China Trade Jitters Investing.com
May-06-19 03:35PM  Allergan Expected to Earn $3.55 a Share TheStreet.com
11:11AM  Should You Buy Allergan (AGN) Ahead of Earnings? Zacks
08:50AM  Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the U.S. PR Newswire
May-05-19 07:00AM  Why Are Investors Passing on Teva Pharmaceutical Industries? Motley Fool
May-03-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Allergan (AGN) Zacks
08:36AM  Ironwood (IRWD) Q1 Earnings & Revenues Miss, Shares Fall Zacks
07:45AM  Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire
07:30AM  Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting PR Newswire
06:28AM  Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down Zacks
06:00AM  Stuck Allergan Stock Needs Blowout Q1 News In Next Weeks Earnings Report InvestorPlace
May-02-19 06:46PM  Breast implants tied to rare cancer to remain on US market Associated Press
02:05PM  Allergan Stock Could Break Below Wedge Pattern Investopedia
07:30AM  Allergan Continues to Display Leadership in Neurosciences with 29 Presentations at 2019 American Academy of Neurology Annual Meeting PR Newswire
07:18AM  3M to buy wound-care product maker Acelity in $6.7bn deal Financial Times
May-01-19 12:05PM  Allergan CEO Saunders wins vote to keep chairman role Reuters
11:58AM  Allergan CEO Saunders wins vote to keep chairman role Reuters
09:34AM  Can Allergan (AGN) Beat Earnings Estimates Again in Q1? Zacks
08:49AM  Allergan CEO Saunders wins vote to keep chairman role Reuters
07:18AM  Allergan investors reject proposal to split chair, chief executive roles Financial Times
06:52AM  Allergan CEO Saunders wins vote to keep chairman role Reuters
06:30AM  Allergan Announces Results from the 2019 Annual General Meeting of Shareholders PR Newswire
Apr-30-19 09:19PM  Allergan to prevail in vote over CEO Saunders' chairman role-sources Reuters
10:32AM  Allergan (AGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks
Apr-29-19 09:43AM  Teva (TEVA) to Report Q1 Earnings: What's in the Cards? Zacks
09:19AM  Allergan and Editas Medicine Announce Initial Data from Natural History Study to Evaluate Patients with Leber Congenital Amaurosis 10 (LCA10) GlobeNewswire
Apr-26-19 04:21PM  Proxy Season Gets Real. What to Watch for This Year Barrons.com
Apr-25-19 11:50AM  Can Keytruda Drive Merck's (MRK) Q1 Earnings and Sales? Zacks
11:15AM  Is a Beat in Store for Editas (EDIT) This Earnings Season? Zacks
07:30AM  Allergan to Showcase Continued Eye Care Innovation with New Data at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting PR Newswire
Apr-24-19 04:29PM  Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates? Zacks
04:25PM  Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-18-19 01:51PM  Jerome Dodson Goes 2 for 2 in 1st Quarter GuruFocus.com
01:43PM  Here's What We Think About Allergan plc's (NYSE:AGN) CEO Pay Simply Wall St.
10:46AM  50 Top Stocks That Billionaires Love Kiplinger
Apr-17-19 11:03AM  Gilead Collaborates With Insitro to Develop NASH Therapies Zacks
Apr-16-19 11:41AM  Allergan Falls as Supreme Court Dismisses Restasis Litigation Zacks
Apr-15-19 04:33PM  Could This Backing Help Allergan's CEO Retain His Chairman Role? Investor's Business Daily
01:59PM  Proxy firms back Allergan in fight against Appaloosa Reuters
11:00AM  New Study Showcases Economic and Community Impact of Allergan's Operations in Ohio PR Newswire
09:54AM  U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents Reuters
09:46AM  U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents Reuters
08:02AM  Proxy firms Glass Lewis and ISS back Allergan in fight against Appaloosa Reuters
07:29AM  Proxy firms Glass Lewis, ISS back Allergan in fight against Appaloosa Reuters
07:00AM  Leading Proxy Advisory Firms ISS and Glass Lewis Support ALL of Allergan Board's Voting Recommendations PR Newswire
Apr-14-19 10:31AM  Heres one way to tell if a company is overpaying its CEO MarketWatch
Apr-10-19 10:46AM  Alkermes Reports Positive Data From Schizophrenia Study Zacks
08:00AM  Allergan Earns 2019 ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Sixth Consecutive Year PR Newswire
Apr-09-19 09:55PM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
02:18PM  Wynn ends A$10 billion acquisition talks with Australia's Crown Resorts Reuters
07:30AM  Allergan to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast PR Newswire
Apr-08-19 06:05PM  Allergan 360° Aesthetics Report Reveals Evolving Beauty Perceptions And Diverse Priorities Around The World PR Newswire
07:30AM  Allergan 360° Aesthetics Report Reveals Evolving Beauty Perceptions And Diverse Priorities Around The World PR Newswire
Apr-05-19 10:34AM  Will Ironwood Suffer From Dependence on Linzess' Progress? Zacks
10:20AM  Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU Zacks
Apr-04-19 05:46PM  Maker of Botox alternative turns toxin on crippling muscle disorder American City Business Journals
04:40PM  Health Canada plans to suspend Allergan's breast implant license Reuters
04:35PM  Health Canada plans to suspend Allergan's breast implant license Reuters
03:39PM  Editas (EDIT) Inks Cross Licensing Agreement with BlueRock Zacks
01:57PM  Health Canada plans to suspend Allergan's breast implant license Reuters
Apr-03-19 10:00AM  Allergan's AMD Drug Lowers Inflammation in Phase III Study Zacks
Apr-02-19 10:10AM  Will Allergan (AGN) Beat Estimates Again in Its Next Earnings Report? Zacks
07:00AM  Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol PR Newswire
Apr-01-19 04:57PM  Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics Zacks
04:00PM  Spero Gets Fast Track Designation for SPR994, Shares Improve Zacks
12:38PM  Drug companies that benefit from the war on opioid addiction Yahoo Finance
Mar-29-19 03:11PM  7 Weak Blue-Chip Stocks to Trim Immediately InvestorPlace
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; and strategic alliance and option agreement with Editas Medicine, Inc. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM